2015Chin J Kidney Dis Invest(Electronic Edition)Requires access

Selection of immunosuppressants for treatment of adult refractory nephrotic syndrome

Junzhou Fu

Open publisher page 0 citations

Abstract

Refractory nephrotic syndrome is very common in the nephrology department, but before its diagnosis is confirmed, the false refractory nephrotic syndrome must be excluded. The diagnosis of false refractory disease may result from incorrect diagnosis, substandard treatment leading to its frequent relapses, improper usage of steroids, poor compliance of patients, and complications existed. For nephrotic syndrome, proper treatments should be used according to the renal pathology. The 2012 KDIGO guidelines for treatment of chronic glomerulonephritis proposed treatment regimens on the basis of latest evidence-based medicine, which involved selection of drug regimens of immunosuppressants for intractable nephrotic syndrome, being of important guiding significance for renal physicians around the world. Key words: Nephrotic syndrome; Refractory; Immunosuppressant

About this research paper

What this paper is about

Refractory nephrotic syndrome is very common in the nephrology department, but before its diagnosis is confirmed, the false refractory nephrotic syndrome must be excluded. The diagnosis of false refractory disease may result from incorrect diagnosis, substandard treatment leading to its frequent relapses, improper usage of steroids, poor compliance of patients, and complications existed. For nephrotic syndrome, proper treatments should be used according to the renal pathology. The 2012 KDIGO guidelines for treatment of chronic glomerulonephritis proposed treatment regimens on the basis of latest evidence-based medicine, which involved selection of drug regimens of immunosuppressants for intractable nephrotic syndrome, being of important guiding significance for renal physicians around the world. Key words: Nephrotic syndrome; Refractory; Immunosuppressant

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Refractory nephrotic syndrome is very common in the nephrology department, but before its diagnosis is confirmed, the false refractory nephrotic syndrome must be excluded. The diagnosis of false refractory disease may result from incorrect diagnosis, substandard treatment leading to its frequent relapses, improper usage of steroids, poor compliance of patients, and complications existed. For nephrotic syndrome, proper treatments should be used according to the renal pathology. The 2012 KDIGO guidelines for treatment of chronic glomerulonephritis proposed treatment regimens on the basis of latest evidence-based medicine, which involved selection of drug regimens of immunosuppressants for intractable nephrotic syndrome, being of important guiding significance for renal physicians around the world. Key words: Nephrotic syndrome; Refractory; Immunosuppressant

Key concepts: Nephrotic syndrome, Medicine, Refractory (planetary science), Nephrology, Intensive care medicine, Internal medicine, Disease, Pediatrics

Related papers

Back to paper searchBrowse research topicsOriginal source
Selection of immunosuppressants for treatment of adult refractory nephrotic syndrome — Research Paper | ScholarLens